OFLOXACIN RELATED COMPOUND A (25 MG) ((RS)-9-FLUORO-2,3-DIHYDRO-3-METHYL-7-OXO-10-(PIPERA-ZIN-1 -YL)-7H-PYRIDO[1,2,3-DE]-1,4-BENZOXAZINE-6-CARBOXYLIC ACID)
|
|
|
- CAS-Nr.
- 82419-52-1
- Englisch Name:
- OFLOXACIN RELATED COMPOUND A (25 MG) ((RS)-9-FLUORO-2,3-DIHYDRO-3-METHYL-7-OXO-10-(PIPERA-ZIN-1 -YL)-7H-PYRIDO[1,2,3-DE]-1,4-BENZOXAZINE-6-CARBOXYLIC ACID)
- Synonyma:
- Desmethyl Ofloxacin;Ofloxacin-3;Ofloxacin EP IMpurity E;Ofloxacin impurity E CRS;Ofloxacin Impurity 5（HCl）;Ofloxacin Related CoMpound A;Ofloxacin USP Related Compound A;Desmethyl Ofloxacin Hydrochloride;Ofloxacin EP Impurity E (USP RC A);(RS)-9-Fluoro-3-methyl-7-oxo-10-(pi
- CBNumber:
- CB7500554
- Summenformel:
- C17H18FN3O4
- Molgewicht:
- 347.34
- MOL-Datei:
- 82419-52-1.mol
|
OFLOXACIN RELATED COMPOUND A (25 MG) ((RS)-9-FLUORO-2,3-DIHYDRO-3-METHYL-7-OXO-10-(PIPERA-ZIN-1 -YL)-7H-PYRIDO[1,2,3-DE]-1,4-BENZOXAZINE-6-CARBOXYLIC ACID) Eigenschaften
- Schmelzpunkt:
- >2500C (dec.)
- Siedepunkt:
- 600.7±55.0 °C(Predicted)
- Dichte
- 1.51±0.1 g/cm3(Predicted)
- storage temp.
- -20°C Freezer
- Löslichkeit
- Aqueous Base (Slightly), DMSO (Slightly, Heated, Sonicated), Methanol (Slightly)
- Aggregatzustand
- solid
- pka
- 5.19±0.40(Predicted)
- Farbe
- Pale Yellow
- BRN
- 4890029
- Major Application
- pharmaceutical (small molecule)
- InChI
- 1S/C17H18FN3O4/c1-9-8-25-16-13-10(15(22)11(17(23)24)7-21(9)13)6-12(18)14(16)20-4-2-19-3-5-20/h6-7,9,19H,2-5,8H2,1H3,(H,23,24)
- InChIKey
- WKRSSAPQZDHYRV-UHFFFAOYSA-N
- SMILES
- FC1=C(N2CCNCC2)C(OCC3C)=C(N3C=C(C(O)=O)C4=O)C4=C1
Sicherheit
- Risiko- und Sicherheitserklärung
- Gefahreninformationscode (GHS)
| Kennzeichnung gefährlicher |
Xn |
|
|
| R-Sätze: |
22 |
|
|
| WGK Germany |
WGK 3 |
|
|
| HS Code |
2934990002 |
|
|
| Speicherklasse |
11 - Combustible Solids |
|
|
| Hazard Classifications |
Acute Tox. 4 Oral |
|
|
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung
|
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H302 |
Gesundheitsschädlich bei Verschlucken. |
Akute Toxizität oral |
Kategorie 4 |
Warnung |
|
P264, P270, P301+P312, P330, P501 |
|
| Sicherheit |
|
OFLOXACIN RELATED COMPOUND A (25 MG) ((RS)-9-FLUORO-2,3-DIHYDRO-3-METHYL-7-OXO-10-(PIPERA-ZIN-1 -YL)-7H-PYRIDO[1,2,3-DE]-1,4-BENZOXAZINE-6-CARBOXYLIC ACID) Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
Pale Yellow Solid
Verwenden
A metabolite of Ofloxacin
OFLOXACIN RELATED COMPOUND A (25 MG) ((RS)-9-FLUORO-2,3-DIHYDRO-3-METHYL-7-OXO-10-(PIPERA-ZIN-1 -YL)-7H-PYRIDO[1,2,3-DE]-1,4-BENZOXAZINE-6-CARBOXYLIC ACID) Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
OFLOXACIN RELATED COMPOUND A (25 MG) ((RS)-9-FLUORO-2,3-DIHYDRO-3-METHYL-7-OXO-10-(PIPERA-ZIN-1 -YL)-7H-PYRIDO[1,2,3-DE]-1,4-BENZOXAZINE-6-CARBOXYLIC ACID) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 95)Lieferanten
- Ofloxacin-3
- Ofloxacin EP Impurity E (USP RC A)
- OFLOXACIN RELATED COMPOUND A (25 MG) ((RS)-9-FLUORO-2,3-DIHYDRO-3-METHYL-7-OXO-10-(PIPERA-ZIN-1 -YL)-7H-PYRIDO[1,2,3-DE]-1,4-BENZOXAZINE-6-CARBOXYLIC ACID)
- 9-Fluoro-2,3-dihydro-3-methyl-7-oxo-10-(1-piperazinyl)-7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
- 9-Fluoro-2,3-dihydro-3-methyl-7-oxo-10-(1-piperazinyl)-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid Hydrochloride
- Desmethyl Ofloxacin Hydrochloride
- (RS)-9-fluoro-2,3-dihydro-3-Methyl-7-oxo-10-(piperazin-1-yl)-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
- Ofloxacin Related CoMpound A
- Ofloxacin Related Compound A (25 mg) ((RS)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-10-(piperazin-1-yl)-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid)
- Ofloxacin EP IMpurity E
- 9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
- (RS)-9-Fluoro-2,3-dihydro-3-methyl-10-(1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid HCl
- Ofloxacin Impurity 5(Ofloxacin EP Impurity E)
- Ofloxacin Related Compound A (25 mg) (9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid)
- 9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
- (RS)-9-Fluoro-3-methyl-7-oxo-10-(pi
- Ofloxacin impurity E CRS
- 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-7-oxo-10-(1-piperazinyl)-
- Ofloxacin Impurity 5（HCl）
- Ofloxacin Related Compound A (25 mg)
- OFLOXACIN RELATED COMPOUND A USP/EP/BP
- OFLOXACIN RELATED COMPOUND A (25 MG) ((RS)-9-FLUORO-2,3-DIHYDRO-3-METHYL-7-OXO-10-(PIPERA-ZIN-1 -YL)-7H-PYRIDO[1,2,3-DE]-1,4-BENZOXAZINE-6-CARBOXYLIC ACID) USP/EP/BP
- (R)-9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
- Desmethyl Ofloxacin (Ofloxacin EP Impurity E)
- Ofloxacin EP Impurity E (Desmethyl Ofloxacin)
- Ofloxacin Related Compound A (9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2 (1478119)
- Ofloxacin USP Related Compound A
- Ofloxacin EP Impurity E (Ofloxacin USP Related Compound A)
- (RS)-9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-c
- 9-Fluoro-2,3-dihydro-3-methyl-7-oxo-10-(1-piperazinyl)-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid - [AC78643]
- (RS)-9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
- Desmethyl Ofloxacin
- 82419-52-1
- C17H19ClFN3O4
- Intermediates & Fine Chemicals
- Various Metabolites and Impurities
- Metabolites & Impurities
- Pharmaceuticals
